FIELD: medicine.
SUBSTANCE: claimed group of inventions relates to medicine, in particular to transplantology. Occluder consists of supporting structure, connected with stopping membrane which contains construct of cell matrix, which includes calls of fibroblasts and in norm secreted by cells of fibroblasts components of endogenically produced extracellular matrix. Method of transcutaneous transluminal closing of hole in heart is realised by means of occluder by installation in defect zone. In addition, method of activation of mammalian tissue vascularisation is performed by means of occluder.
EFFECT: group of inventions makes it possible to close defects of organs, restore injured tissues, activate vascularisation in defect place.
21 cl, 21 ex, 19 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENT'S ORAL DISEASES (VERSIONS) | 2007 |
|
RU2498808C9 |
BIOENGINEERED CONSTRUCT FOR TISSUE IMPLANTATION AND METHOD FOR MAKING SAID BIOENGINEERED CONSTRUCT (VERSIONS) | 2008 |
|
RU2461622C2 |
TISSUE STRUCTURES OBTAINED BY BIOENGINEERING, AND METHODS FOR THEIR PRODUCTION AND APPLICATION | 2011 |
|
RU2645473C2 |
CELL CONTENT REMOVAL AND RECOVERY IN ORGANS AND TISSUES | 2012 |
|
RU2635478C9 |
SKIN EQUIVALENT AND METHOD FOR ITS PRODUCTION | 2006 |
|
RU2342164C2 |
METHOD FOR PRODUCTION OF COLLAGEN-LAMININ MATRIX FOR HEALING OF ULCERS, BURNS AND WOUNDS OF HUMAN SKIN | 2018 |
|
RU2736480C2 |
ORGANIZATION OF CELLS SIMILAR TO TISSUE AND MACROSCOPICAL DESIGNS SIMILAR TO TISSUE OBTAINED BY MEANS OF CULTURE OF MACROMASS OF CELLS AND METHOD OF MACROMASS CULTURE | 2004 |
|
RU2335538C2 |
ENGINEERED LEATHER EQUIVALENT, METHOD FOR PRODUCTION THEREOF AND PRODUCTS OBTAINED THEREFROM | 2017 |
|
RU2820590C2 |
EXTRACELLULAR MATRIX COMPOSITIONS FOR TREATING CANCER | 2009 |
|
RU2523339C2 |
MULTILAYERED VASCULAR TUBES | 2011 |
|
RU2522966C2 |
Authors
Dates
2012-12-27—Published
2007-02-07—Filed